WO2007149868A3 - Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles - Google Patents
Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles Download PDFInfo
- Publication number
- WO2007149868A3 WO2007149868A3 PCT/US2007/071580 US2007071580W WO2007149868A3 WO 2007149868 A3 WO2007149868 A3 WO 2007149868A3 US 2007071580 W US2007071580 W US 2007071580W WO 2007149868 A3 WO2007149868 A3 WO 2007149868A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanoparticles
- inflammatory
- bacterial
- controlled release
- release encapsulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
This invention pertains to the formulation of nanoparticles that have intrinsic antimicrobial and anti-inflammatory activity. The nanoparticles can be impregnated with one or more therapeutic agents and thereby enhance the antimicrobial and/or anti-inflammatory activity of such agents, and also other properties that the therapeutic agents provide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/303,166 US20110135742A1 (en) | 2006-06-20 | 2007-06-19 | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81528606P | 2006-06-20 | 2006-06-20 | |
US60/815,286 | 2006-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007149868A2 WO2007149868A2 (en) | 2007-12-27 |
WO2007149868A3 true WO2007149868A3 (en) | 2008-07-03 |
Family
ID=38834319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/071580 WO2007149868A2 (en) | 2006-06-20 | 2007-06-19 | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
Country Status (2)
Country | Link |
---|---|
US (1) | US20110135742A1 (en) |
WO (1) | WO2007149868A2 (en) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
JP5292304B2 (en) | 2006-12-01 | 2013-09-18 | アンテリオス, インコーポレイテッド | Peptide nanoparticles and uses thereof |
BRPI0719756A2 (en) | 2006-12-01 | 2014-01-21 | Anterios Inc | Amphiphilic Nanoparticles |
US10016451B2 (en) | 2007-05-31 | 2018-07-10 | Anterios, Inc. | Nucleic acid nanoparticles and uses therefor |
US9044477B2 (en) * | 2007-12-12 | 2015-06-02 | Allergan, Inc. | Botulinum toxin formulation |
ES2448572T3 (en) * | 2008-05-29 | 2014-03-14 | Basf Se | Antimicrobial composition containing antimicrobials covalently bound with an interpenetrating polyurethane-silicon network |
EP2303026B1 (en) | 2008-06-17 | 2020-09-09 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
EP2116237A1 (en) | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
US20100111857A1 (en) | 2008-10-31 | 2010-05-06 | Boyden Edward S | Compositions and methods for surface abrasion with frozen particles |
US8545856B2 (en) | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US9050070B2 (en) | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8731840B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8221480B2 (en) | 2008-10-31 | 2012-07-17 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US9060934B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8788211B2 (en) | 2008-10-31 | 2014-07-22 | The Invention Science Fund I, Llc | Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition |
US8409376B2 (en) | 2008-10-31 | 2013-04-02 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8798932B2 (en) | 2008-10-31 | 2014-08-05 | The Invention Science Fund I, Llc | Frozen compositions and methods for piercing a substrate |
US8721583B2 (en) | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8545855B2 (en) | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8762067B2 (en) | 2008-10-31 | 2014-06-24 | The Invention Science Fund I, Llc | Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data |
US9060931B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US8731841B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8603495B2 (en) | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US9072688B2 (en) | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8545857B2 (en) | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US9072799B2 (en) | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9050317B2 (en) | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8603494B2 (en) | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US9060926B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US20100111845A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8551505B2 (en) | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8793075B2 (en) | 2008-10-31 | 2014-07-29 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8725420B2 (en) | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8485861B2 (en) | 2008-10-31 | 2013-07-16 | The Invention Science Fund I, Llc | Systems, devices, and methods for making or administering frozen particles |
US20150079160A1 (en) * | 2009-06-02 | 2015-03-19 | Concept Medical Research Private Limited | Non-implantable medical device coated with nano-carriers for delivering one or more drugs to a body site |
JP6131194B2 (en) * | 2011-01-24 | 2017-05-17 | アンテリオス, インコーポレイテッド | Empty nanoparticle composition and use thereof for treating dermatological symptoms |
KR20140063616A (en) | 2011-07-20 | 2014-05-27 | 브라이엄 영 유니버시티 | Hydrophobic ceragenin compounds and devices incorporating same |
WO2013078252A1 (en) | 2011-11-22 | 2013-05-30 | Qd Vision, Inc. | Quantum dot-containing compositions including an emission stabilizer, products including same, and method |
EP3225113B1 (en) | 2012-05-02 | 2020-09-02 | Brigham Young University | Methods for making ceragenin particulate materials |
TWI455725B (en) * | 2012-05-31 | 2014-10-11 | Univ Chia Nan Pharm & Sciency | Chitosan microcapsules and method of making the same |
CN105451742B (en) | 2013-01-07 | 2021-04-06 | 布莱阿姆青年大学 | Methods for reducing cell proliferation and treating certain diseases |
WO2014164418A1 (en) | 2013-03-11 | 2014-10-09 | North Carolina State University | Functionalized environmentally benign nanoparticles |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
CA2907082C (en) | 2013-03-15 | 2021-05-04 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
US10226550B2 (en) * | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
CN117731591A (en) | 2016-11-21 | 2024-03-22 | 艾里奥治疗公司 | Transdermal delivery of large agents |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
WO2021076020A2 (en) * | 2019-10-14 | 2021-04-22 | Андрей Михайлович ГАПОНОВ | Pharmaceutical composition for the treatment and prophylaxis of infectious inflammatory diseases |
WO2023043813A1 (en) * | 2021-09-14 | 2023-03-23 | The American University In Cairo | Nanoguard |
CN115230264B (en) * | 2022-07-11 | 2023-06-27 | 北京科技大学 | Intelligent controlled release fresh-keeping composite film capable of preventing contact surface from changing color |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030099718A1 (en) * | 2001-04-23 | 2003-05-29 | Burrell Robert Edward | Treatment of mucosal membranes |
US20050281886A1 (en) * | 2004-05-06 | 2005-12-22 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895724A (en) * | 1985-06-07 | 1990-01-23 | Pfizer Inc. | Chitosan compositions for controlled and prolonged release of macromolecules |
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
US6096344A (en) * | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
US6649192B2 (en) * | 1996-07-29 | 2003-11-18 | Universidade De Santiago De Compostela | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
US6197322B1 (en) * | 1997-12-23 | 2001-03-06 | Kimberly-Clark Worldwide, Inc. | Antimicrobial structures |
WO1999045784A1 (en) * | 1998-03-12 | 1999-09-16 | Oji Paper Co., Ltd. | Bactericides |
US6734210B2 (en) * | 2000-02-24 | 2004-05-11 | Rolland F. Hebert | Therapeutically improved salts of azelaic acid |
WO2001064164A2 (en) * | 2000-02-28 | 2001-09-07 | Genesegues, Inc. | Nanocapsule encapsulation system and method |
US6451773B1 (en) * | 2000-03-31 | 2002-09-17 | Cognis Corporation | Chitosan formulation with azelaic acid and other actives for the treatment of acne |
ES2221530B1 (en) * | 2002-07-19 | 2006-02-16 | Universidad De Santiago De Compostela | NANOPARTICLES FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS, PROCEDURE FOR THE ELABORATION OF SUCH PARTICLES AND COMPOSITION THAT CONTAIN THEM. |
EP1562543A1 (en) * | 2002-11-21 | 2005-08-17 | J.P.M.E.D. Ltd. | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
US20040156873A1 (en) * | 2003-02-10 | 2004-08-12 | Gupta Shyam K. | Topically Bioavailable Acne and Rosacea Treatment Compositions |
JP2006525333A (en) * | 2003-05-02 | 2006-11-09 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | Biodegradable nanoparticles incorporating highly hydrophilic and positively charged drugs |
US8043632B2 (en) * | 2003-08-18 | 2011-10-25 | E. I. Du Pont De Nemours And Company | Process for making antimicrobial articles by reacting chitosan with amino-reactive polymer surfaces |
US20060141046A1 (en) * | 2004-05-06 | 2006-06-29 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
-
2007
- 2007-06-19 US US12/303,166 patent/US20110135742A1/en not_active Abandoned
- 2007-06-19 WO PCT/US2007/071580 patent/WO2007149868A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030099718A1 (en) * | 2001-04-23 | 2003-05-29 | Burrell Robert Edward | Treatment of mucosal membranes |
US20050281886A1 (en) * | 2004-05-06 | 2005-12-22 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
Also Published As
Publication number | Publication date |
---|---|
WO2007149868A2 (en) | 2007-12-27 |
US20110135742A1 (en) | 2011-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007149868A3 (en) | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles | |
WO2011030158A3 (en) | Antimicrobial composition | |
WO2009064767A3 (en) | Bactericidal nanofibers, and methods of use thereof | |
HK1225961A1 (en) | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces | |
WO2008085578A3 (en) | Anti-microbial compositions and devices and methods of using the same | |
WO2009121970A3 (en) | Coating material | |
WO2008009379A3 (en) | Active ingredient combinations having insecticide and acaricide properties | |
WO2010062396A3 (en) | Virus like particle compositions and methods of use | |
EP2687287A3 (en) | Delivery particles | |
EP2687590A3 (en) | Delivery particles | |
EP2160152A4 (en) | Combined fibrinolytic and antimicrobial catheter and uses thereof | |
WO2006099232A3 (en) | Antimicrobial pet wipes | |
WO2010079468A3 (en) | Delivery particle | |
WO2008131089A3 (en) | Reduction of infection associated with medical device | |
WO2008084495A3 (en) | Novel agricultural composition | |
WO2007109330A3 (en) | S1p receptor modulating compounds | |
IL213489A0 (en) | Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces | |
MX2012000827A (en) | Particles incorporating antimicrobial agents. | |
WO2010059366A3 (en) | Antimicrobial foamable soaps | |
WO2007126824A3 (en) | Methods and systems for sterilization | |
WO2008104310A3 (en) | Antimicrobial compositions | |
WO2011142858A3 (en) | Chlorotoxin variants, conjugates, and methods for their use | |
WO2006089665A3 (en) | Active ingredient combinations having insecticide and acaricide properties | |
PT3001905T (en) | Active agent combinations with insecticides and acaricide properties | |
WO2009141633A3 (en) | Polysaccharide nanofibres having antimicrobial properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07798767 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07798767 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12303166 Country of ref document: US |